Truist Securities lowers Arcus Biosciences stock price target on trial failure

Dec 12, 2025 - 18:00

1

Truist Securities lowers Arcus Biosciences stock price target on trial failure

Related Posts

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGT

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Target Corp...

Mar 21, 2025 1

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025 3

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025 0

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025 4

Elon Musk says DOGE cuts necessary, but face headwinds according to Fox poll

Elon Musk says DOGE cuts necessary, but face headwinds ...

Mar 21, 2025 1

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 5